Turning Breakthrough Discoveries
into Medicines
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
Key Focus areas
We are developing a portfolio of drug candidates in the field of Neurodegenerative Disease, Immuno-Oncology and Rare Disease as well as developing Genomic-based target discovery platform for neurodegenerative target and biomarker discovery.
Meet the Team
1STBIO was founded by experienced veterans in the life science industry with an aim to assemble a team with scientific, clinical, and business expertise. Since its inception, seasoned professionals in their respective fields have joined together with an unwavering focus on discovering and developing therapeutics to improve patients’ lives.
Latest News
1ST Biotherapeutics and SK Biopharmaceuticals Announce Exclusive Global License Agreement for Parkinson’s Disease Candidate ‘1ST-104’
September 17, 2026
퍼스트바이오·SK바이오팜, 파킨슨병 치료 후보물질 ‘1ST-104’ 글로벌 독점 라이선스 계약 체결
September 17, 2026
신주발행공고
September 4, 2026
신주발행공고
September 4, 2026
Where We’re Located
1ST Biotherapeutics, Inc.
338, Gwanggyojungang-ro, Gwanggyowoominewv, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
Suite C509-510, C803, C806-809